Summary:The effects of intracarotidly injected endothe lin (ET)-1 (0.01-3 nmol) on the local cerebral blood vol ume (CBV) in the parietotemporal cortex were examined by the photoelectric method in 17 anesthetized cats. CBV reflects the cumulative dimensions of the cerebral mi crovessels. Low doses of ET -1 (0.01 and 0.1 nmol) elic ited mild but significant reductions in CBV without changes in the systemic arterial blood pressure (SABP). High doses of ET -1 (3 nmol) initially induced marked de clines of CBV, which were attributable to the significant falls in SABP. CBV subsequently exhibited significant increases. The CBV increases were not secondary to the accompanying elevations of SABP, since they were unEndothelin (ET) is a 21-amino acid peptide, orig inally isolated by Yanagisawa et a1. (1988) from cul tured endothelial cells of the porcine aorta. Subse quently, three distinct isoforms of ET, designated as ET-1, ET-2, and ET-3 , were identified (Inoue et aI., 1989). Among these, only ET-1 is known to ex ist in vascular endothelial cells (Bloch et aI., 1989). ET-1, ET-2, and ET-3 are demonstrated in various nonvascular tissues including those of the brain (Sakurai et aI., 1992). Recently, two different sub types of human ET receptors, ETA and ETB, have been isolated (Sakurai et aI., 1992). The ETA recep tors exhibit a higher affinity to ET-1 than to ET-3 , while the ET B receptors show an equipotent affinity to all three ETs. In acute cerebrovascular disorders Received March 17, 1993; final revision received May 3, 1993; accepted June 10, 1993.Address correspondence and reprint requests to Dr. M. Kobari at Department of Neurology, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160, Japan.Abbreviations used: BBB, blood-brain barrier; CBV, cerebral blood volume; EDRF, endothelium-derived relaxing factor; ET, endothelin; L-NMMA, � -monomethyl-L-arginine; SABP, sys temic arterial blood pressure.
64affected by inhibition of the SABP changes after prein jection of BQ-123 (1 mg/kg), an ET antagonist specific to the ET A receptors. The CBV increases, however, were prevented by continuous administration of �-mono methyl-L-arginine (0.35 mg/kg/min), an inhibitor of nitric oxide synthesis, plus BQ-123. We conclude that while low doses of intravascular ET -1 constrict the cerebral microvessels, high doses of ET-l dilate the cerebral mi crovessels through the induction of nitric oxide probably in the cerebrovascular endothelium. Key Words: Cerebral blood volume-Cerebral microvessel-Endothelin Endothelium-derived relaxing factor-Nitric oxide Photoelectric method.